Successful reactivation of hepatic Mrp transporters in endotoxininduced cholestasis in mice by the CAR activator 6,7-Dimethylesculetin
|
|
- Alison Hensley
- 5 years ago
- Views:
Transcription
1 Successful reactivation of hepatic Mrp transporters in endotoxininduced cholestasis in mice by the activator 6,7-Dimethylesculetin Ina V. Martin *, Sebastian Voigt*, Michael Trauner, Christian Trautwein and Andreas Geier Dept. of Gastroenterology & Hepatology, University Hospital Aachen (UKA), Germany Division of Gastroenterology & Hepatology, Laboratory for Experimental Hepatology, University Hospital Zurich (USZ), Switzerland Falk Bile Acid Meeting Amsterdam, June 14th 2008
2 Hepatic organic anion transporters in obstructive cholestasis reduced maintained / increased Oatps MDR3/Mdr2 Mdr1 Mrp3 Mrp4 Pro-cholestatic (causal) Anti-cholestatic (adaptive)
3 Hepatic organic anion transporters in inflammatory cholestasis reduced maintained / increased LPS Oatps MDR3/Mdr2 Mdr1 Mrp3 Mrp4 Pro-cholestatic (causal) Anti-cholestatic (adaptive)
4 Hepatic organic anion transporters in inflammatory cholestasis LPS Shuttling of nuclear receptors IL-6 TNFα Il-1β IL-1β Oatp1 Mdr2 Mdr1 Mrp3 Mrp4 α nuclear protein CO 4h 8h 16h kd TNFα IL-1β 60 Siewert BBRC 2004 Geier Am J Physiol 2005 Ghose Nuclear Receptors 2004
5 Regulation of hepatic transport systems by nuclear receptors Mrp4 Mrp3 Activators as targets for intervention Oatp1 Oatp2 Oatp4 HNF4 HNF1 - RAR Stat5 HNF1 HNF1 HNF1 RAR SHP - FXR RAR FXR RAR FXR LRH-1 FXR TCPOBOP Phenobarbital 6,7-Dimethylesculetin PCN Atorvastatin Rifampicin GW4064 UDCA/TUDCA Geier Biochim Biophys Acta 2007 Karpen J Hepatology 2005
6 Induction of hepatic transport systems in healthy liver and CBDL Mrp4 Mrp3 Bili-Gluc -SO 2 Ugt1a1 TCPOBOP PB Sult2a1 PCN Atorvastatin Oatp1 Oatp2 Oatp4 Mrp3 Mrp4 Wagner Hepatology 2005
7 Induction of hepatic transport systems in inflammatory cholestasis Mrp3 30% RAR? Rosiglitazone? FXR 31% IR-1 DR-2 Ghose J Hepatology 2007
8 Background & Aims Inflammatory cholestasis has been previously characterized as a result of reduced organic anion transporter expression mediated by a decreased expression and altered subcellular localization of class II nuclear hormone receptors (NHR). We hypothesized that treatment with the activator 6,7-dimethylesculetin (DE) in endotoxemic mice may induce expression and putatively a nuclear redistribution of NHR leading to a maintained transporter gene expression. 6,7-dimethylesculetin as the active substance of Yin Chin has been used in Asian traditional medicine to treat neonatal jaundice for centuries.
9 Yin Chin (6,7-Dimethylesculetin) enhances bilirubin clearance by activating humanized transgenic mice YinChin/ 6,7-DE Artemisia capillaris Huang J Clin Invest 2004
10 Methods 6,7-DE or corn oil (Sham) C57/BL6 (25g; n=5) LPS Animal model - Inflammatory liver injury was induced in male C57/BL6 mice by intraperitoneal injection of endotoxin (0,5 mg/kg). - Intervention: Simultaneous application of 6,7- Dimethylesculetin (Sigma; 100 mg/kg) or corn oil only by i.p. injection. Livers were harvested after 4h and 16h h mrna Expression (RT-PCR, Northern) - hepatic transporters (,, -4) - nuclear receptors (,, FXR, RAR,, Lrh-1) -cytokines(tnfα, IL-1β) immunohistochemistry in fixed liver sections
11 Results & Conclusions (Abstract) Treatment with the activator 6,7-DE in endotoxemia induces NHR gene expression with maximum effects on and Lrh-1 RNA at 16 hours compared to an extensive suppression in control mice. Immunohistochemistry staining provided no definite DE-specific effect on localization, since sham controls were also characterized by a partial nuclear redistribution of the receptor protein. At 16h transcriptional and Lrh-1 activation was associated with a prominent induction of Mrp3 and a maintained expression of (and ) compared to a substantial decrease in controls. This study provides a potential protective interventional approach to selectively modify an otherwise unselective negative hepatic acute phase response during endotoxemia at the molecular level.
12 Hypothesis: targeting in inflammatory cholestasis Mrp4 Mrp3?? LRH-1 LRH-1 6,7-DE Mrp3 TNFα Il-1β IL-1β?
13 Acknowledgements Christoph Dietrich, Aschaffenburg Carsten Gartung, Minden Ina V. Martin Sebastian Voigt Hella Scotland Anne Porn Ann-Kathrin Vehr Alexander Minkenberg Joba Arikkat Sonja Strauch Michael Trauner, Graz Peter Mertens, Aachen Frank Lammert, Bonn Steven Dooley, Mannheim Elke Roeb, Giessen Bruno Stieger, Zürich Gerd Kullak-Ublick, Zürich M. Ananthanarayanan, New York
Hepatic Transporter Proteins involved in Bile Formation
Bile salt synthesis Hepatic Transporter Proteins involved in Bile Formation Basolateral membrane transporter proteins fx: NTCP uptake of bile salts OATP bulky organic anions Canalicular membrane transporter
More informationCholestasis leads to hepatic and systemic accumulation
CAR and PXR Agonists Stimulate Hepatic Bile Acid and Bilirubin Detoxification and Elimination Pathways in Mice Martin Wagner, 1 Emina Halilbasic, 1 Hanns-Ulrich Marschall, 2 Gernot Zollner, 1 Peter Fickert,
More informationThe regulation of genes that are essential to many
GASTROENTEROLOGY 2005;129:735 740 NEW CONCEPTS IN GASTROENTEROLOGY Nuclear Receptor Ligands: Rational and Effective Therapy for Chronic Cholestatic Liver Disease? JAMES L. BOYER Liver Center, Department
More informationOrganic solute transporter alpha-beta (Ost -
Mouse Organic Solute Transporter Deficiency Enhances Renal Excretion of Bile Acids and Attenuates Cholestasis Carol J. Soroka, 1 Albert Mennone, 1 Lee R. Hagey, 2 Nazzareno Ballatori, 3 and James L. Boyer
More informationBile Acids and Liver Fibrosis Causative Agent and Therapeutic Tool
Bile Acids and Liver Fibrosis Causative Agent and Therapeutic Tool Peter Fickert, Andrea Fuchsbichler, Tarek Moustafa, Gernot Zollner, Emina Halilbasic, Ulrike Stöger, Cord Langner, Helmut Denk, and Michael
More informationBecause they are potent detergents, synthesis of bile
High Expression of the Bile Salt-Homeostatic Hormone Fibroblast Growth Factor 19 in the Liver of Patients with Extrahepatic Cholestasis Frank G. Schaap, 1 Niels A. van der Gaag, 2 Dirk J. Gouma, 2 and
More informationREVIEW Nuclear receptors as therapeutic targets in cholestatic liver diseases
British Journal of Pharmacology (2009), 156, 7 27 2008 The Authors Journal compilation 2008 The British Pharmacological Society All rights reserved 0007-1188/08 www.brjpharmacol.org REVIEW Nuclear receptors
More informationFalk Symposium 156: Genetics in Liver Disease. Pharmacogenetics. Gerd Kullak-Ublick
Falk Symposium 156: Genetics in Liver Disease Pharmacogenetics Gerd Kullak-Ublick Division of Clinical Pharmacology and Toxicology Department of Internal Medicine University Hospital Zurich Freiburg, 8.
More informationFasting induces basolateral uptake transporters of the SLC family in the liver via HNF4 and PGC1
Page 1 of 28 Articles in PresS. Am J Physiol Gastrointest Liver Physiol (July 19, 2007). doi:10.1152/ajpgi.00175.2007 Fasting induces basolateral uptake transporters of the SLC family in the liver via
More informationInhibition of Human Hepatic Bile Acid Transporters as Contributing Factors to Drug-Induced Liver Injury
Inhibition of Human Hepatic Bile Acid Transporters as Contributing Factors to Drug-Induced Liver Injury Kenneth R. Brouwer, Ph.D., RPh Chief Scientific Officer DDI Meeting June 2017 Seattle, Washington
More informationThe antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism
Supplementary Information The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism Address correspondence to Yong Li (yongli@xmu.edu.cn, Tel: 86-592-218151) GW464 CDCA Supplementary
More informationRegulation of the cell surface expression and transport capacity of BSEP by small chemical molecules
Regulation of the cell surface expression and transport capacity of by small chemical molecules Hisamitsu Hayashi and Yuichi Sugiyama Dept. of Molecular Pharmacokinetics, Graduate School of Pharmaceutical
More informationGenetic cholestasis. Peter Jansen Liver Center Academic Medical Center Amsterdam
Genetic cholestasis Peter Jansen Liver Center Academic Medical Center Amsterdam Genetic cholestasis Proteins and genes Genetic cholestatic diseases Lessons from ko/mutant models A new MDR3 phenotype A
More informationPathophysiology of Bile Secretion
Pathophysiology of Bile Secretion Martin C. Carey, D.Sc., M.D. Division of Gastroenterology, Brigham and Women s Hospital and Department of Medicine, Harvard Medical School Boston, MA, U.S.A. Functions
More informationThe role of protein synthesis and degradation in the posttranscriptional regulation of rat multidrug resistance-associated protein 2 (Mrp2, Abcc2)
Molecular Pharmacology This article has Fast not been Forward. copyedited Published and formatted. The on final May version 25, 2005 may differ as doi:10.1124/mol.105.013144 from this version. The role
More informationPlasma exposure levels from individual mice 4 hours post IP administration at the
Supplemental Figure Legends Figure S1. Plasma exposure levels of MKC-3946 in mice. Plasma exposure levels from individual mice 4 hours post IP administration at the indicated dose mg/kg. Data represent
More informationFarnesoid X receptor represses hepatic human APOA gene expression
Research article Farnesoid X receptor represses hepatic human APOA gene expression Indumathi Chennamsetty, 1 Thierry Claudel, 2 Karam M. Kostner, 3 Anna Baghdasaryan, 2 Dagmar Kratky, 1 Sanja Levak-Frank,
More informationConstitutive Regulation of P450s by Endocrine Factors
References: Constitutive Regulation of P450s by Endocrine Factors Meyer UA. Endo-xenobiotic crosstalk and the regulation of cytochromes P450. Drug Metab Rev 39:639-46, 2007. Waxman DJ and O Connor C. Growth
More informationMultidrug resistance associated protein 4 (MRP4)
Mrp4 / Mice Have an Impaired Cytoprotective Response in Obstructive Cholestasis Albert Mennone, 1 Carol J. Soroka, 1 Shi-Ying Cai, 1 Kathy Harry, 1 Masashi Adachi, 2 Lee Hagey, 3 John D. Schuetz, 2 and
More informationcontributes to reversal of biliary fibrosis by Popov et al.
Supplementary data to MS Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of biliary fibrosis by Popov et al. Supplementary table 1. Primers and probes used in quantitative
More informationCitation for published version (APA): Plass, J. R. M. (2005). Function and regulation of the human bile salt export pump Groningen: s.n.
University of Groningen Function and regulation of the human bile salt export pump Plass, Jacqueline Regina Maria IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if
More informationXingguo Cheng, Jonathan Maher, Matthew Z. Dieter, and Curtis D. Klaassen
0090-9556/05/3309-1276 1282$20.00 DRUG METABOLISM AND DISPOSITION Vol. 33, No. 9 Copyright 2005 by The American Society for Pharmacology and Experimental Therapeutics 3988/3045816 DMD 33:1276 1282, 2005
More informationIn vivo dynamic metabolic imaging of obstructive cholestasis in mice
Am J Physiol Gastrointest Liver Physiol 296: G1091 G1097, 2009. First published February 26, 2009; doi:10.1152/ajpgi.90681.2008. In vivo dynamic metabolic imaging of obstructive cholestasis in mice Feng-Chieh
More informationDMD Fast Forward. Published on December 15, 2008 as DOI: /dmd DMD #
DMD Fast This Forward. article has not Published been copyedited on and December formatted. The 15, final 2008 version as may doi:10.1124/dmd.108.023630 differ from this version. DMD #23630 1 Regulation
More informationThe Role of Protein Synthesis and Degradation in the Post- Transcriptional Regulation of Rat Multidrug Resistance- Associated Protein 2 (Mrp2, Abcc2)
0026-895X/05/6803-701 710$20.00 MOLECULAR PHARMACOLOGY Vol. 68, No. 3 Copyright 2005 The American Society for Pharmacology and Experimental Therapeutics 13144/3045720 Mol Pharmacol 68:701 710, 2005 Printed
More informationCholestatic liver dysfunction during critical illness
Cholestatic liver dysfunction during critical illness Yoo-Mee Vanwijngaerden Lies Langouche Dieter Mesotten Greet Van den Berghe Department of Cellular and Molecular Medicine Laboratory of Intensive Care
More informationElevated copper impairs hepatic nuclear receptor function in Wilson s disease
The Journal of Clinical Investigation Research article Elevated copper impairs hepatic nuclear receptor function in Wilson s disease Clavia Ruth Wooton-Kee, 1 Ajay K. Jain, 2 Martin Wagner, 3 Michael A.
More informationPUBLICATIONS. cells. J. Physiol. (London) 517P:91P (Manchester, England, UK).
277 PUBLICATIONS Abstracts Haddad JJ, Land SC (1999). Differential activation of oxygen-responsive transcription factors over fetal-to-neonatal alveolar oxygen tensions in rat fetal distal lung epithelial
More informationProtective Effects of 6-Ethyl Chenodeoxycholic Acid, A. Cholestasis
JPET Fast This article Forward. has not Published been copyedited on and January formatted. 11, The final 2005 version as DOI:10.1124/jpet.104.079665 may differ from this version. JPET#79665 1 Protective
More informationA traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR
A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR Wendong Huang, Jun Zhang, and David D. Moore Department of Molecular and Cellular Biology, Baylor College
More informationCholestatic Expression Pattern of Sinusoidal and Canalicular Organic Anion Transport Systems in Primary Cultured Rat Hepatocytes
Original Articles Cholestatic Expression Pattern of Sinusoidal and Canalicular Organic Anion Transport Systems in Primary Cultured Rat Hepatocytes S. JANE RIPPIN, BRUNO HAGENBUCH, PETER J. MEIER, AND BRUNO
More informationRole of nuclear bile acid receptor FXR in intestinal bacterial overgrowth and translocation
Role of nuclear bile acid receptor FXR in intestinal bacterial overgrowth and translocation Antonio Moschetta University of Bari, Consorzio Mario Negri Sud, Santa Maria Imbaro (Chieti), Italy www.negrisud.it
More informationManagement of cholestatic diseases Today and tomorrow
12th Paris Hepatology Conference Management of cholestatic diseases Today and tomorrow Paris 15 January 2019 U. Beuers Department of Gastroenterology & Hepatology Tytgat Institute for Liver and Intestinal
More informationA shift in paradigm towards human biologybased systems for cholestatic-liver disease
A shift in paradigm towards human biologybased systems for cholestatic-liver disease Fozia Noor Systems Toxicology In Vitro Metabolomics Biochemical Engineering Institute Saarland University, Germany BioMed21
More informationEffect of High-fat or High-glucose Diet on Obesity and Visceral Adipose Tissue in Mice
ACTA ACADEMIAE MEDICINAE SINICAE 410011 0731-85295846 lixia2014@vip. 163. com 4 C57BL /6 20-1 mrna 20 P < 0. 05 O 20 P > 0. 05 M2 P < 0. 05-1 mrna P < 0. 05 P > 0. 05 R589. 2 DOI 10. 3881 /j. issn. 1000-503X.
More informationCAROL J. SOROKA, JOHN M. LEE, FRANCESCO AZZAROLI, AND JAMES L. BOYER
Cellular Localization and Up-regulation of Multidrug Resistance Associated Protein 3 in Hepatocytes and Cholangiocytes During Obstructive Cholestasis in Rat Liver CAROL J. SOROKA, JOHN M. LEE, FRANCESCO
More informationInt J Clin Exp Med 2015;8(2): /ISSN: /IJCEM
Int J Clin Exp Med 2015;8(2):1691-1702 www.ijcem.com /ISSN:1940-5901/IJCEM0004080 Original Article Oral administration of oleanolic acid, isolated from Swertia mussotii Franch, attenuates liver injury,
More informationSupplementary Figure 1.
Supplementary Figure 1. Female Pro-ins2 -/- mice at 5-6 weeks of age were either inoculated i.p. with a single dose of CVB4 (1x10 5 PFU/mouse) or PBS and treated with αgalcer or control vehicle. On day
More informationIMO-8400, a novel TLR7, TLR8 and TLR9 antagonist, psoriasis
IMO-8400, a novel TLR7, TLR8 and TLR9 antagonist, inhibits disease development in mouse models of psoriasis Weiwen e Ja Jiang, Fu-Gang Zhu, Dong Yu, Ekambar R. Kandimalla, a a, Nicola La Monica, and Sudhir
More informationThe many faces of MDR 3 deficiency
The many faces of MDR 3 deficiency Relevance of canalicular membrane transporting proteins for human liver disease Peter LM Jansen and Marleen de Vree Academic Medical Center Amsterdam, The Netherlands
More informationSUPPLEMENTARY INFORMATION
doi: 1.138/nature7221 Brown fat selective genes 12 1 Control Q-RT-PCR (% of Control) 8 6 4 2 Ntrk3 Cox7a1 Cox8b Cox5b ATPase b2 ATPase f1a1 Sirt3 ERRα Elovl3/Cig3 PPARα Zic1 Supplementary Figure S1. stimulates
More informationBile acid receptor FXR: metabolic regulator in the gut. Sungsoon Fang
Bile acid receptor FXR: metabolic regulator in the gut Sungsoon Fang Nuclear hormone receptor 1905: Ernest Starling coined hormone 1929: Estrogen structure 1958: Estrogen receptor by Elwood Jensen 1985:
More informationActivation of Bile Acid Signaling Shapes the Gut Microbiota to Improve Diabetes and Fatty Liver Disease
Activation of Bile Acid Signaling Shapes the Gut Microbiota to Improve Diabetes and Fatty Liver Disease John Chiang, Ph.D. Northeast Ohio Medical University Rootstown, OH, USA International Conference
More informationTherapeutic effect of baicalin on experimental autoimmune encephalomyelitis. is mediated by SOCS3 regulatory pathway
Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway Yuan Zhang 1,2, Xing Li 1,2, Bogoljub Ciric 1, Cun-gen Ma 3, Bruno Gran 4, Abdolmohamad
More informationSupplemental Figures: Supplemental Figure 1
Supplemental Figures: Supplemental Figure 1 Suppl. Figure 1. BM-DC infection with H. pylori does not induce cytotoxicity and treatment of BM-DCs with H. pylori sonicate, but not heat-inactivated bacteria,
More informationGeneral Laboratory methods Plasma analysis: Gene Expression Analysis: Immunoblot analysis: Immunohistochemistry:
General Laboratory methods Plasma analysis: Plasma insulin (Mercodia, Sweden), leptin (duoset, R&D Systems Europe, Abingdon, United Kingdom), IL-6, TNFα and adiponectin levels (Quantikine kits, R&D Systems
More informationDrug-induced liver injury
Drug-induced liver injury Vincent Wong MBChB(Hons), MD, FRCP, FHKCP, FHKAM Professor, Department of Medicine and Therapeutics Director, Cheng Suen Man Shook Foundation Centre for Hepatitis Studies Deputy
More informationHepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis
Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis Yaping Liu, 1 Jane Binz, 2 Mary Jo Numerick, 3 Steve Dennis, 3 Guizhen Luo, 1 Bhasha Desai,
More informationBile acids initiate cholestatic liver injury by triggering a hepatic specific inflammatory response. Supplementary Results
Bile acids initiate cholestatic liver injury by triggering a hepatic specific inflammatory response Shi-Ying Cai 1, Xinshou Ouyang 1, Yonglin Chen 1, Carol J. Soroka 1, Juxian Wang 2, Albert Mennone 1,
More informationSupplemental Table 1: Demographics and characteristics of study participants. Male, n (%) 3 (20%) 6 (50%) Age, years [mean ± SD] 33.3 ± ± 9.
SUPPLEMENTAL DATA Supplemental Table 1: Demographics and characteristics of study participants Lean (n=15) Obese (n=12) Male, n (%) 3 (20%) 6 (50%) Age, years [mean ± SD] 33.3 ± 9.5 44.8 ± 9.1 White, n
More informationEffect of BD Matrigel Matrix Overlay and BD Matrigel Matrix Thin Coat on CYP450 Activities in Cryo Human Hepatocytes. Rongjun Zuo.
Effect of BD Matrigel Matrix Overlay and BD Matrigel Matrix Thin Coat on CYP450 Activities in Cryo Human Hepatocytes Rongjun Zuo November 10, 2010 Topics Overview of Hepatocyte Products P450 Induction
More informationCHAPTER 5 RESULTS Previous study: cell culture and organotypical slices
45 CHAPTER 5 RESULTS 5.1. Previous study: cell culture and organotypical slices Initial experiments have been conducted to ensure that the tet-on system works. A neuronal cell culture from mice expressing
More informationConstitutive Regulation of P450s by Endocrine Factors
Constitutive Regulation of P450s by Endocrine Factors References: Meyer UA. Endo-xenobiotic crosstalk and the regulation of cytochromes P450. Drug Metab Rev 39:639-46, 2007. Waxman DJ and O Connor C. Growth
More informationSupplementary Information
Supplementary Information TABLE S1. SUBJECT CHARACTERISTICS* Normal Control Subjects Subjects with Asthma p Value Number 23 48 Age (years) 35±10 35±10 0.75 Sex, M:F (% F) 9:12 (57) 17:26 (60) 0.76 FEV1
More informationFxr -/- Mice Adapt to Biliary Obstruction by Enhanced Phase I Detoxification. and Renal Elimination of Bile Acids
Fxr -/- Mice Adapt to Biliary Obstruction by Enhanced Phase I Detoxification and Renal Elimination of Bile Acids Hanns-Ulrich Marschall 1*, Martin Wagner 2, Karl Bodin 3, Gernot Zollner 2, Peter Fickert
More informationPCEUT 527 Enzyme Induction: Biochemical Mechanisms 2/13/15
PCEUT 527 Enzyme Induction: Biochemical Mechanisms 2/13/15 1. General Principles 2. Increase in enzyme content through transcription 3. Protein degradation 4. Protein stabilization Why Does Induction Occur?
More informationTreatment of Chronic Cholestasis: What We Know and What We Will Know?
REVIEW Treatment of Chronic Cholestasis: What We Know and What We Will Know? James L. Boyer HISTORICAL PERSPECTIVES For many years, the treatment of cholestatic liver disease was limited to surgical relief
More informationBritish Liver Transplant Group Pathology meeting September Leeds cases
British Liver Transplant Group Pathology meeting September 2014 Leeds cases Leeds Case 1 Male 61 years Liver transplant for HCV cirrhosis with HCC in January 2014. Now raised ALT and bilirubin,? acute
More informationSupplementary fig. 1. Crystals induce necroptosis does not involve caspases, TNF receptor or NLRP3. A. Mouse tubular epithelial cells were pretreated
Supplementary fig. 1. Crystals induce necroptosis does not involve caspases, TNF receptor or NLRP3. A. Mouse tubular epithelial cells were pretreated with zvad-fmk (10µM) and exposed to calcium oxalate
More informationInclusion/Exclusion Criteria
The Immunomodulatory Effects of Intensification among ART-suppressed Patients with Incomplete CD4 Recovery Peter W. Hunt, Nancy Shulman, Tim Hayes, Viktor Dahl, Ma Somsouk, Nick Funderburg, Alan L. Landay,
More informationDepartment of Internal Medicine and the Department of Pathology. Wake Forest University
Bile Acid Transporters Paul A. Dawson, Tian Lan, Anuradha Rao Department of Internal Medicine and the Department of Pathology. Wake Forest University School of Medicine. Winston-Salem, NC 27157 Corresponding
More informationSupplemental Materials for. Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to. FTY720 during neuroinflammation
Supplemental Materials for Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY7 during neuroinflammation This file includes: Supplemental Table 1. EAE clinical parameters of
More informationSupplementary Figure 1. Expression of CUGBP1 in non-parenchymal liver cells treated with TGF-β
Supplementary Figures Supplementary Figure 1. Expression of CUGBP1 in non-parenchymal liver cells treated with TGF-β and LPS. Non-parenchymal liver cells were isolated and treated with or without TGF-β
More informationNature Medicine: doi: /nm.4324
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Supplementary Figure 1. Kinetics of SnCs development in surgically-induced OA and effect of GCV-induced SnC clearance on OA disease progression
More informationUnderstanding the molecular actions of bile acid receptor activation for treating human liver disease
Understanding the molecular actions of bile acid receptor activation for treating human liver disease Purpose and aims The interplay between the liver, the gastrointestinal tract and lipid metabolism is
More informationFigure S1 Generation of γ-gt DTR transgenic mice. (A) Schematic construct of the transgene. (B)
Figure S1 Generation of γ-gt DTR transgenic mice. (A) Schematic construct of the transgene. (B) PCR identified expected hhb-egf band (left panel) and HA tag band (right) in kidneys of transgenic (TG) mice
More informationAnnals of Hepatology 2005; 4(2): April-June: Concise Review
Annals of Hepatology 2005; 4(2): April-June: 77-99 Concise Review Annals of Hepatology Transcriptional regulation of hepatobiliary transport systems in health and disease: Implications for a rationale
More informationDrug Induced Liver Disease Role of the Pathologist. Disclosure. DILI can never be excluded. Romil Saxena, MD. Dr. Saxena has nothing to Disclose
Drug Induced Liver Disease Role of the Pathologist Romil Saxena, MD Disclosure Dr. Saxena has nothing to Disclose DILI can never be excluded #1 DILI has no specific pattern of injury it can mimic any and
More informationCrucial role for human Toll-like receptor 4 in the development of contact allergy to nickel
Supplementary Figures 1-8 Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel Marc Schmidt 1,2, Badrinarayanan Raghavan 1,2, Verena Müller 1,2, Thomas Vogl 3, György
More informationRole of metabolism in Drug-Induced Liver Injury (DILI) Drug Metab Rev. 2007;39(1):
Role of metabolism in Drug-Induced Liver Injury (DILI) Drug Metab Rev. 2007;39(1):159-234 Drug Metab Rev. 2007;39(1):159-234 Drug Metab Rev. 2007;39(1):159-234 A schematic representation of the most relevant
More informationViral Load-Dependent Effects of Liver Injury and Regeneration on HBV. Replication in Mice
JVI Accepts, published online ahead of print on 20 June 2012 J. Virol. doi:10.1128/jvi.01087-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10 11 12 13 14
More informationHepatotoxicity: A Drug-Induced Cholestatic Pattern
Review articles Laura Morales M., 1 Natalia Vélez L., 1 Octavio Germán Muñoz M., MD. 2 1 Medical Student in the Faculty of Medicine and the Gastrohepatology Group at the Universidad de Antioquia in Medellín,
More informationRole of Farnesoid X Receptor in the Determination of. Liver Transcriptome during Postnatal Maturation in
Role of Farnesoid X Receptor in the Determination of Liver Transcriptome during Postnatal Maturation in Mice Lai Peng 1, Stephanie Piekos 1, Grace L. Guo 2, and Xiao-bo Zhong 1 1 Department of Pharmaceutical
More informationRegulation of P450. b. competitive-inhibitor but not substrate. c. non-competitive inhibition. 2. Covalent binding to heme or protein
10. Inhibition of P450 Regulation of P450 a. competitive-2 chemicals metabolized by same isoform b. competitive-inhibitor but not substrate c. non-competitive inhibition 11. Induction of P450 1. Non-covalent
More informationThe encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23- induced production of the cytokine GM-CSF
CORRECTION NOTICE Nat.Immunol. 12, 568 575 (2011) The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23- induced production of the cytokine GM-CSF Mohamed El-Behi, Bogoljub Ciric, Hong
More informationSUPPLEMENTARY INFORMATION
1. Supplementary Figures and Legends Supplementary Fig. 1. S1P-mediated transcriptional regulation of integrins expressed in OP/monocytoid cells. Real-time quantitative PCR analyses of mrna for two integrins,
More informationProlonged cholestasis triggered by hepatitis A virus infection and variants of the hepatocanalicular phospholipid and bile salt transporters
710 CASE REPORT September-October, Vol. 11 No.5, 2012: 710-714 Prolonged cholestasis triggered by hepatitis A virus infection and variants of the hepatocanalicular phospholipid and bile salt transporters
More informationPart-I: Screening. 3.1 Assessment of non-toxic concentration of test compounds in RAW cells. Results
Part-I: Screening Our strategy was to look for compounds which can inhibit HMGB1 (high mobility group box 1) release in activated macrophages and check effect of screened compound on endotoxemic mice.
More informationAlcoholic Hepatitis. Christian Doppler Research Laboratory for Gut Inflammation Medical University Innsbruck. Herbert Tilg
Alcoholic Hepatitis Christian Doppler Research Laboratory for Gut Inflammation Medical University Innsbruck Herbert Tilg Overview Background I: Alcoholic steatohepatitis (ASH) is a severe and often life-threatening
More informationAssessment of inhibitory effect of many therapeutically important drugs on bile acid transport by NTCP, BSEP and other transporters
ct 6, 26 Falk Symposium 155; XIX International Bile Acid Meeting Assessment of inhibitory effect of many therapeutically important drugs on bile acid transport by NTCP, BSEP and other transporters Kazuya
More informationInterface hepatitis in PBC: Prognostic marker and therapeutic target
Interface hepatitis in PBC: Prognostic marker and therapeutic target Raoul Poupon Service d Hépatologie, Hôpital Saint-Antoine, Paris Faculté de Médecine Pierre & Marie Curie, Paris Key features of
More informationIn vivo effect of anti-inflammatory compounds on HIV-1 gp120 -mediated brain inflammation
In vivo effect of anti-inflammatory compounds on HIV-1 gp120 -mediated brain inflammation Tamima Ashraf, PhD candidate Supervisor: Dr. Reina Bendayan University of Toronto, Leslie Dan Faculty of Pharmacy,
More informationIdentification of a new FXR target gene: fibrinogen Bβ
Chapter 5 Identification of a new FXR target gene: fibrinogen Bβ Jacqueline R.M. Plass, Mariska Geuken, Janette Heegsma, Peter L.M. Jansen, and Klaas Nico Faber. Division of Gastroenterology and Hepatology,
More informationNew recommendations for immunocompromised patients
New recommendations for immunocompromised patients Hepatitis E Virus (HEV): Transmission, incidence and presentation Emerging evidence regarding HEV transmission from blood components and dietary consumption
More informationRisk stratification in PBC
Risk stratification in PBC Christophe Corpechot Reference Center for Inflammatory Biliary Diseases Saint-Antoine hospital, Paris, France What is currently known (background) PBC : chronic, progressive
More informationDepartment of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas
0090-9556/04/3211-1265 1271$20.00 DRUG METABOLISM AND DISPOSITION Vol. 32, No. 11 Copyright 2004 by The American Society for Pharmacology and Experimental Therapeutics 1281/1178713 DMD 32:1265 1271, 2004
More informationSupplemental Table 1. Primers used for RT-PCR analysis of inflammatory cytokines Gene Primer Sequence
Supplemental Table 1. Primers used for RT-PCR analysis of inflammatory cytokines Gene Primer Sequence IL-1α Forward primer 5 -CAAGATGGCCAAAGTTCGTGAC-3' Reverse primer 5 -GTCTCATGAAGTGAGCCATAGC-3 IL-1β
More informationKupffer cell depletion with liposomal clodronate prevents suppression of Ntcp expression in endotoxin-treated rats
Journal of Hepatology 42 (2005) 102 109 www.elsevier.com/locate/jhep Kupffer cell depletion with liposomal clodronate prevents suppression of Ntcp expression in endotoxin-treated rats Ekkehard Sturm 1,
More informationMicroRNAs Modulate the Noncanonical NF- B Pathway by Regulating IKK Expression During Macrophage Differentiation
MicroRNAs Modulate the Noncanonical NF- B Pathway by Regulating IKK Expression During Macrophage Differentiation Tao Li 1 *, Michael J. Morgan 1 *, Swati Choksi 1, Yan Zhang 1, You-Sun Kim 2#, Zheng-gang
More informationBSEP inhibition and Drug Induced Liver Injury
BSEP inhibition and Drug Induced Liver Injury Gerry Kenna Pharmaceutical Director, Safer Medicines Trust www.safermedicines.org Drug Safety Consultant Overview Drug Induced Liver Injury (DILI) BSEP inhibition
More informationZurich Open Repository and Archive. Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy
University of Zurich Zurich Open Repository and Archive Winterthurerstr. 190 CH-8057 Zurich http://www.zora.uzh.ch Year: 2010 Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis
More informationcorn oil. The controls received an equivalent
Effect of 2,3,7,8-Tetrachlorodibenzo-p-dioxin on the Biliary Excretion of Indocyanine Green in Rat by Slang W1. Hwang* Chlorinated dibenzodioxins have been found as contaminants of various technical chlorinated
More informationUniversity of Groningen. Non-anastomotic biliary strictures after liver transplantation Hoekstra, Harm
University of Groningen Non-anastomotic biliary strictures after liver transplantation Hoekstra, Harm IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to
More informationXV Jornada de Avances en Hepatología Málaga 20 y 21 de Mayo de Barrera intestinal en la cirrosis. Agustín Albillos
XV Jornada de Avances en Hepatología Málaga 20 y 21 de Mayo de 2016 Barrera intestinal en la cirrosis Agustín Albillos Hospital Universitario Ramón y Cajal Universidad de Alcalá, Ciberehd Madrid, Spain
More informationCholestasis: human disease and experimental animal models
Annals of Hepatology 2003; 2(4): OctoberDecember: 150158 Concise Review Annals of Hepatology Cholestasis: human disease and experimental animal models Emilio Alberto RodríguezGaray, MD, PhD 1 Abstract
More informationPXR Prevents Cholesterol Gallstone Disease by Regulating Biosynthesis and Transport of Bile Salts
GASTROENTEROLOGY 2011;140:2095 2106 PXR Prevents Cholesterol Gallstone Disease by Regulating Biosynthesis and Transport of Bile Salts JINHAN HE,* SHIGERU NISHIDA, MEISHU XU,* MAKOTO MAKISHIMA, and WEN
More informationSupplementary Figure 1. Confocal immunofluorescence showing mitochondrial translocation of Drp1. Cardiomyocytes treated with H 2 O 2 were prestained
Supplementary Figure 1. Confocal immunofluorescence showing mitochondrial translocation of Drp1. Cardiomyocytes treated with H 2 O 2 were prestained with MitoTracker (red), then were immunostained with
More informationEFFECT OF DEXAMETHASONE TREATMENT ON THE EXPRESSION AND FUNCTION OF TRANSPORT PROTEINS IN SANDWICH-CULTURED RAT HEPATOCYTES
0090-9556/04/3208-834 839$20.00 DRUG METABOLISM AND DISPOSITION Vol. 32, No. 8 Copyright 2004 by The American Society for Pharmacology and Experimental Therapeutics 1367/1167793 DMD 32:834 839, 2004 Printed
More informationOATP1B1 is a member of the organic anion. Liver X Receptor a and Farnesoid X Receptor Are Major Transcriptional Regulators of OATP1B1
LIVER BIOLOGY/PATHOBIOLOGY Liver X Receptor a and Farnesoid X Receptor Are Major Transcriptional Regulators of OATP1B1 Henriette E. Meyer zu Schwabedissen, 1,2 Kerstin Böttcher, 2 Amarjit Chaudhry, 3 Heyo
More informationSupplementary Figures for TSC1 controls macrophage polarization to prevent inflammatory disorder by Linnan Zhu et al
Supplementary Figures for TSC1 controls macrophage polarization to prevent inflammatory disorder by Linnan Zhu et al Suppl. Fig. 1 Tissue DN C Proteins kd TSC1-17 TSC 1 loxp bp -48-285 ctin PEMs Neutrophils
More information